Related Experiment Video
Updated: Mar 19, 2026

Treatment of Ankle Osteoarthritis with Total Ankle Replacement Through a Lateral Transfibular Approach
Published on: January 24, 2018
Pulmonary embolism and mortality following total ankle replacement: a data linkage study using the NJR data set
Razi Zaidi1, Alexander MacGregor2, Suzie Cro3
1Institute of Orthopaedics & Musculoskeletal Science, Royal National Orthopaedic Hospital NHS Trust, London, UK.
The 90-day mortality rate after total ankle replacement (TAR) is low, with no deaths attributed to pulmonary embolism (PE). However, patients with comorbidities face a significantly higher risk of PE following TAR.
Area of Science:
- Orthopedic Surgery
- Vascular Surgery
- Public Health
Background:
- Total ankle replacement (TAR) is an established procedure for end-stage ankle arthritis.
- Understanding post-operative complications such as mortality and pulmonary embolism (PE) is crucial for patient safety.
- Existing data on TAR-specific PE incidence and mortality is limited.
Purpose of the Study:
- To determine the 90-day and 1-year mortality rates following total ankle replacement (TAR).
- To assess the incidence of 90-day pulmonary embolism (PE) after TAR.
- To identify risk factors associated with PE after TAR.
Main Methods:
- A data-linkage study utilizing the UK National Joint Registry (NJR) and Hospital Episodes Statistics (HES) databases.
- Deterministic linkage of NJR and HES data for patient cohort identification.
- Analysis of HES data for PE occurrence within 90 days post-TAR and NJR data for mortality.
Main Results:
- The 90-day mortality rate following TAR was 0.13%, and the 1-year mortality rate was 0.72%.
- No deaths were directly attributed to PE.
- The 90-day PE incidence after primary TAR was 0.51%; only one PE occurred after revision surgery.
- Patients with a Charlson Comorbidity Index score > 0 had a 13-fold increased risk of PE (p=0.003).
Conclusions:
- Total ankle replacement (TAR) is associated with a low incidence of pulmonary embolism (PE).
- Multiple comorbidities represent a significant risk factor for PE development post-TAR.
- Risk stratification and proactive management of comorbidities are essential for improving patient outcomes after TAR.
More Related Videos
05:39Author Spotlight: A Non-Intubated Video-Assisted Thoracoscopic Surgery with Multimodal Analgesia and Sevoflurane Inhalation Anesthesia
Published on: May 26, 2023
08:50Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
Related Concept Videos
Pulmonary Embolism I: Introduction
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism III: Nursing Management
Peripheral Artery Disease V: Postoperative Nursing Management
Ankle Joint